PLX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protalix Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 2.69 USD -0.37% Market Closed

Market Cap: $216.7m

P	Protalix Biotherapeutics Inc AMEX:PLX	US
	Nissin Foods Holdings Co Ltd TSE:2897	JP
	OneMain Holdings Inc NYSE:OMF	US
	Poste Italiane SpA F:7PI	IT
	Fortescue Metals Group Ltd ASX:FMG	AU
D	DRDGOLD Ltd JSE:DRD	ZA
C	Chevron Corp F:CHV	US
N	Nikon Corp DUS:NKN	JP
C	Cisco Systems Inc F:CIS	US
	Dentsu Group Inc F:DEN0	JP
S	Societe BIC SA OTC:BICEF	FR
	Paramount Global NASDAQ:PARA	US
	YTO Express Group Co Ltd SSE:600233	CN
	Omni-Lite Industries Canada Inc XTSX:OML	US
G	Gartner Inc DUS:GGRA	US

Profitability Summary

Protalix Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

69%

Strong 3Y Average Gross Margin

56%

Declining Gross Margin

72% > 69%

Healthy Operating Margin

29%

Low 3Y Average Operating Margin

Operating Margin is Increasing

18% > 29%

Healthy Net Margin

23%

Low 3Y Average Net Margin

Net Margin is Increasing

13% > 23%

Healthy Free Cash Flow Margin

10%

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-16% > 10%

Exceptional ROE

31%

Positive 3Y Average ROE

Positive 3Y Average ROIC

10%

ROIC is Increasing

28% > 37%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.